高级检索
当前位置: 首页 > 详情页

Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/Drospirenone (Yasmin (R)) in Healthy Chinese Women A Randomized, Open-Label, Controlled, Multicentre Trial

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China [2]Peking China Japan Friendship Hosp, Beijing, Peoples R China [3]Int Peace Matern & Child Hlth Hosp, China Welf Inst, Shanghai, Peoples R China [4]Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China [5]Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China [6]Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China [7]Peking Chao Yang Hosp, Beijing, Peoples R China [8]Peking Obstet Gynecol Hosp, Beijing, Peoples R China [9]Peking Univ, Hosp 3, Beijing 100871, Peoples R China [10]Tongji Med Univ, Family Planning Res Inst, Shanghai, Peoples R China [11]Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China [12]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
出处:
ISSN:

摘要:
Objective: To evaluate and compare the contraceptive efficacy, bleeding pattern, side effects and other positive effects of a combined oral contraceptive (COC) containing drospirenone (DRSP) [Yasmin (R)] with those of a COC containing desogestrel (DSG) in healthy Chinese women. Methods: This was a randomized, open-label, controlled, multicentre study of 768 healthy Chinese women requiring contraception. The subjects were randomized to ethinylestradiol (EE) 30 mu g/DRSP 3 mg (n = 573) or EE 30 mu g/DSG 150 mu g (n = 195), at a ratio of 3 : 1. Each individual was treated for 13 cycles. Further visits were required at cycle 4, cycle 7, cycle 10 and cycle 13 of treatment. Weight, height and body mass index were evaluated at each visit. The Menstrual Distress Questionnaire (MDQ) was administered at baseline, visit 3 (cycle 7) and visit 5 (after cycle 13). Results: Baseline characteristics were similar between the two groups (p > 0.05). The Pearl Index (method failure) for EE/DRSP was 0.208 per 100 women-years, which was lower than that for EE/DSG (0.601 per 100 women-years). There were no significant differences between the treatment groups with regard to bleeding patterns. According to the MDQ subscale, improvements in water retention and increases in appetite during the intermenstrual period and in water retention and general well-being during the menstrual period in the EE/DRSP group (-0.297, -0.057, 0.033 and 0.150, respectively) were significantly improved compared with the EE/DSG group (-0.108, 0.023, 0.231 and -0.023, respectively) [all p < 0.05]. Other values that improved in both groups, particularly improvement in breast pain and tenderness and skin condition, were more evident in the EE/DRSP group (18.0%, 89/494; 12.6%, 62/494) than in the EE/DSG group (11.3%, 19/168; 5.4%, 9/168). Mean weight increased in the EE/DSG group (0.57 kg) while there was a significant decrease in mean weight (-0.28 kg) in the EE/DRSP group (p<0.01). Conclusions: Both EE/DRSP and EE/DSG have good contraceptive efficacy and a comparable bleeding pattern. EE/DRSP had a more favourable effect on weight and premenstrual symptoms than EE/DSG.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区:
出版当年[2008]版:
Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2008版] 出版当年五年平均[2004-2008] 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者单位: [1]Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China [*1]Peking Union Med Coll Hosp, Dept Obstet & Gynecol, 1 Shuaifu, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China [*1]Peking Union Med Coll Hosp, Dept Obstet & Gynecol, 1 Shuaifu, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)